A leading immuno-oncology biotech company with a pipeline of novel, first-in-class clinical stage assets needed medical support for multiple clinical and medical affairs activities in Europe and the United States.
Our support included providing advice and assistance with the following:
We also assessed portfolio expansion opportunities and other corporate development activities from a clinical development and medical perspective.
View Additional Immunotherapy Case Studies